PREVALENCIA DE AISLAMIENTOS BACTERIANOS RESISTENTES A CARBAPENÉMICOS OBTENIDOS A PARTIR DE UROCULTIVOS EN EL HOSPITAL DE CLÍNICAS. SAN LORENZO, PARAGUAY (2017-2018)
PDF (Español (España))

Keywords

Klebsiella
Acinetobacter
Pseudomonas
Drug Resistance
Microbial
Carbapenemase
Urine culture

How to Cite

Cardozo-Torres, H. A., Auxiliadora Florentín, A. M., Velázquez-Aguayo, G. R., & Ortellado-Canese, J. (2023). PREVALENCIA DE AISLAMIENTOS BACTERIANOS RESISTENTES A CARBAPENÉMICOS OBTENIDOS A PARTIR DE UROCULTIVOS EN EL HOSPITAL DE CLÍNICAS. SAN LORENZO, PARAGUAY (2017-2018). Discover Medicine, 3(2). https://doi.org/10.2300/dm.v3i2.3142

Abstract

Background: Antibiotic resistance is currently a serious problem around the world. The aim of this study was to determine the prevalence of carbapenemase-producing bacteria in urine cultures and their resistance mechanisms.
Methods: A retrospective cross-sectional study was performed, which included 10.959 urine cultures from June 2017 to June 2018 at the Central Laboratory of the Hospital de Clínicas. The identification of bacterial species was performed with Vitek 2-C®. For the in vitro sensitivity study, the minimum inhibitory concentrations (MIC) were determined according to the Clinical and Laboratory Standards Institute guidelines.
Results: 333 isolates of k. pneumoniae, P. aeruginosa, and Acinetobacter spp were obtained in a period of 13 months, of which 116 (34.83%) were resistant to carbapenems; 16 isolates (29.09%) of K. pneumoniae had the KPC mechanism, 24 (43.64%) MBL and 15 (27.27%) other mechanisms. 6 (13.33%) P. aeruginosa were MBL type, and 39 (86.67%) were found with other mechanisms. For Acinetobacter spp., 1 (6.25%) was MBL type and 15 (93.75%) had other resistant mechanisms. The average age of patients with KPC and MBL strains was 49,45 ± 26,5 years, 66% (31/47) were male, and 34% (16/47) female. The greatest number of resistant strains were from the adult emergency room with 24,14% (28/116). Other bacterial species were not considered.
Conclusion: Early detection of resistant strains and their resistance mechanisms is essential to target a better therapy and patient management. A greater commitment and a better strategy are required to prevent the spread of these infections that threaten the hospital environment.

https://doi.org/10.2300/dm.v3i2.3142
PDF (Español (España))

References

Muñoz C, Zumarán C, González T, Wozniak A, Castillo C, García P. Evaluación de test rápidos y diseño de una estrategia para la detección y caracterización de carbapenemasas en cepas de bacilos gramnegativos. Rev Chilena Infectol. 2017;34:326-32.

Nordmann P. Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge. Med Mal Infect. 2014;44(2):51-6.

Ocampos Ugarte JG, Takahasi Alvarez VE. Enterobacterias productoras de carbapenemasas en pacientes del Servicio de Clínica Médica del Hospital Nacional de Itauguá. Rev Virtual Soc Parag Med Int. 2015;2:33-42.

Hanemaaijer NM, Nijhuis RHT, Slotboom BJ, Mascini EM, van Zwet AA. New screening method to detect carriage of carbapenemase-producing Enterobacteriaceae in patients within 24 hours. J Hosp Infect. 2014;87(1):47-9.

Viqueira AQ, Milán BH, Francés MVS. Enterobacterias productoras de carbapenemasas en un hospital pediátrico/Carbapenem-resistant enterobacteriaceae in a pediatric hospital. Acta Pediatr Esp. 2016;74(8):183.

Rodríguez CH, Nastro M, Dabos L, Vay C, Famiglietti A. Frecuencia de aislamiento y resistencia a los antimicrobianos de Acinetobacter spp. recuperadas de pacientes atendidos en un hospital universitario de la Ciudad Autónoma de Buenos Aires, Argentina. Rev Argent Microbiol. 2014;46(4):320-4.

Pan American Health Organization/World Health Organization. First finding of carbapenemases of type New Delhi Metallo-lactamase (NDM) in Latin America. 22 noviembre 2011. Washington, D.C.: PAHO/WHO; 2011.

Pan American Health Organization. Epidemiological Alert: Nosocomial transmission of NDM-type multiresistant bacteria. 19 diciembre 2012, Washington, D.C.: PAHO/WHO; 2012.

Pasteran F, Mora MM, Albornoz E, Faccone D, Franco R, Ortellado J, et al. Emergence of genetically unrelated NDM-1-producing Acinetobacter pittii strains in Paraguay. J Antimicrob Chemother. 2014;69(9):2575-8.

Melgarejo N, Martinez M, Franco R, Falcón M. Enterobacterias resistentes a Carbapenemes por producción de KPC, aisladas en hospitales de Asunción y Departamento Central. Rev salud pública parag. 2013;3(1):30-5.

Molin Queste COM. Phenotypic detection of Carbapenemases in P. aeruginosa in patients attending the Hospital de Clinicas in San Lorenzo, from February to July 2013. Mem Inst Investig Cienc Salud. 2016;14(1):25-31.

Arca-Blanco A, de la Fuente-Aguado J. Resistencia a carbapenemas en Pseudomonas aeruginosa aisladas en urocultivos: prevalencia y factores de riesgo. Rev Esp Quimioter. 2017;30(3):195-200.

Ruiz-Garbajosa P, Cantón R. Epidemiología de los bacilos gramnegativos multirresistentes. Rev Esp Quimioter. 2016;29(1):21-5.

EUCAST: Clinical breakpoints and dosing antibiotics [internet]. Eucast.org. 2018 [citado el 20 de octubre de 2018]. Disponible en: http://www.eucast.org/clinical_breakpoints

Clinical & Laboratory Standards Institute: CLSI Guidelines [internet]. Clinical & Laboratory Standards Institute. 2018 [citado el 20 de octubre de 2018]. Disponible en http://clsi.org

Miranda SP. Documentos Técnicos para el laboratorio clínico: Recomendaciones para detección de carbapenemasas en enterobacterias y pseudomonas aeruginos. En: Referencia DLBNyd, editor. Chile: Instituto de Salud Pública de Chile; 2018.

Molin Queste COM, Laconich Romero MM, Zubeldía Céspedes AE, Agüero Fernandez MF, Pérez Martínez H, Quiñonez A et al. Prevalencia de Klebsiella pneumoniae-KPC en Urocultivos de pacientes del Hospital de Clínicas, Julio 2014 – Abril 2015. En: 10.º Congreso Paraguayo de Infectología [internet]. Asunción: Sociedad Paraguaya de Infectología; 2015 [citado el 20 de octubre de 2018]. Disponible en: http://www.spi.org.py/wp-content/uploads/2015/11/108.-Prevalencia-de-Klebsiella-pneumoniae-KPC-en-Urocultivos-de-Pacientes-del-Hospital-de-Cl%C3%ADnicas-Julio-201.pdf

Pacheco R, Osorio L, Correa AM, Villegas MV. Prevalencia de bacterias Gram negativas portadoras del gen blaKPC en hospitales de Colombia. Biomedica. 2014;34(1):81-90.

Vega Bogado ME, Bernal C, Rodríguez M, Takahasi V. Normas 2017 de contención de infecciones por gérmenes productores de carbapenemasas del Hospital Nacional de Itauguá, Paraguay. Rev Nac(Itauguá). 2017;9(1):92-114 ción y Departamento Central. Rev salud pública parag. 2013;3(1):30-5.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2023 Hernan Antonio Cardozo-Torres, Ana María Auxiliadora Florentín, Gladys Raquel Velázquez-Aguayo, Juana Ortellado-Canese

Downloads

Download data is not yet available.